Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer



Status:Active, not recruiting
Conditions:Colorectal Cancer, Colorectal Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/24/2016
Start Date:July 1996

Use our guide to learn which trials are right for you!

Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in
chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die. Combining radiation therapy and chemotherapy may shrink the tumor so that it can be
removed during surgery.

PURPOSE: Phase II trial to study the effectiveness of radiation therapy and chemotherapy
followed by surgery and combination chemotherapy in treating patients who have stage II or
stage III rectal cancer.

OBJECTIVES: I. Determine the local recurrence rate, disease-free survival, and overall
survival of patients with stage II or III rectal cancer treated with neoadjuvant
radiotherapy and fluorouracil followed by surgical resection and adjuvant fluorouracil and
leucovorin calcium. II. Determine the toxicity rate in patients treated with this regimen.
III. Correlate failure-free survival with ultrasound-determined preoperative staging in
patients treated with this regimen. IV. Determine the quality of life of patients treated
with this regimen. V. Determine if toxicity due to treatment, daily stool frequency, sexual
dysfunction, and disease-free survival correlates with quality of life parameters in
patients treated with this regimen. VI. Correlate clinical selection criteria with ability
to perform sphincter-sparing surgery in patients treated with this regimen. VII. Determine
post-chemoradiotherapy pathological response, margin status, and lymph node status and
correlate these factors with initial clinico-pathologic findings in patients treated with
this regimen.

OUTLINE: Patients undergo pelvic radiotherapy once daily five days a week for 5 weeks
followed by boost radiotherapy twice daily for 7 days. Patients also receive neoadjuvant
fluorouracil IV continuously over days 1-4 and 36-40. Patients undergo surgical resection
4-6 weeks after completion of radiotherapy. At 4 weeks after surgery, patients receive
adjuvant leucovorin calcium IV and fluorouracil IV once daily five days a week. Treatment
continues every 4 weeks for 4 courses in the absence of disease progression or unacceptable
toxicity. Quality of life is assessed at baseline, at the completion of pelvic and boost
radiotherapy, at 4 weeks after completion of chemoradiotherapy (prior to surgery), and then
at 3, 6, and 12 months after completion of study therapy. Patients are followed every 3
months for 2 years, every 4 months for 3 years, and then annually thereafter.

PROJECTED ACCRUAL: A total of 23-41 patients will be accrued for this study.

DISEASE CHARACTERISTICS:

- Histologically confirmed adenocarcinoma of the rectum

- Tumor extending through bowel wall (T3) OR

- Fixation to surrounding structures (T4) OR

- Nodal involvement by endorectal ultrasound (N1-2)

- Tumor extending through bowel wall, but not fixed (T3) must be:

- At least 4 cm or at least 40% of bowel circumference OR

- Accompanied by nodal involvement

- Evidence of transmural penetration confirmed by 2 of the following:

- CT scan

- Pelvic MRI

- Transrectal ultrasound

- Physical exam

- Proximal extent of tumor must not extend higher than 12 cm above dentate line and
must be below pelvic peritoneal reflexion or sacral promontory

- Regional lymph node involvement allowed

- No distant metastases by CT scan of abdomen and pelvis or chest x-ray

PATIENT CHARACTERISTICS:

- Age: Over 18

- Performance status: ECOG 0-1

- Life expectancy: At least 2 years

- Hematopoietic:

- Leukocyte count greater than 4,000/mm3

- Platelet count at least 100,000/mm3

- Hemoglobin greater than 10 g/dL

- Hepatic:

- SGOT and SGPT less than 1.5 times normal

- Bilirubin less than 1.5 mg/dL

- Renal: Creatinine less than 1.8 mg/dL

- Other:

- Not pregnant or nursing

- Negative pregnancy test

- No other prior or concurrent malignancy within the past 5 years except inactive
non-melanoma skin cancer or carcinoma in situ of the cervix

- No psychiatric condition that would preclude informed consent

- No other serious medical illness that would limit survival

PRIOR CONCURRENT THERAPY:

- Biologic therapy: Not specified

- Chemotherapy: No prior chemotherapy for rectal cancer

- Endocrine therapy: Not specified

- Radiotherapy: No prior radiotherapy for rectal cancer

- Surgery: No prior surgery for rectal cancer, except diagnostic biopsy
We found this trial at
17
sites
Lansdale, Pennsylvania 19446
?
mi
from
Lansdale, PA
Click here to add this to my saved trials
Altoona, Pennsylvania 16602
?
mi
from
Altoona, PA
Click here to add this to my saved trials
Drexel Hill, Pennsylvania
?
mi
from
Drexel Hill, PA
Click here to add this to my saved trials
Flemington, New Jersey 08822
?
mi
from
Flemington, NJ
Click here to add this to my saved trials
Harrisburg, Pennsylvania 17104
?
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Johnstown, Pennsylvania 15905
?
mi
from
Johnstown, PA
Click here to add this to my saved trials
Lakewood, New Jersey 08701
?
mi
from
Lakewood, NJ
Click here to add this to my saved trials
Langhorne, Pennsylvania 19047
?
mi
from
Langhorne, PA
Click here to add this to my saved trials
175 Madison Avenue
Mount Holly, New Jersey 08060
(609) 914-6000
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County Virtua Memorial is a...
?
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
255 W Lancaster Ave
Paoli, Pennsylvania 19301
(484) 565-1000
Paoli Memorial Hospital Paoli is recognized regionally and nationally for outstanding medical and surgical services,...
?
mi
from
Paoli, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19111
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pottstown, Pennsylvania 19464
?
mi
from
Pottstown, PA
Click here to add this to my saved trials
Reading, Pennsylvania 19612
?
mi
from
Reading, PA
Click here to add this to my saved trials
Red Bank, New Jersey 07701
?
mi
from
Red Bank, NJ
Click here to add this to my saved trials
Toms River, New Jersey 08755
?
mi
from
Toms River, NJ
Click here to add this to my saved trials
Trenton, New Jersey 08629
?
mi
from
Trenton, NJ
Click here to add this to my saved trials
West Grove, Pennsylvania 19390
?
mi
from
West Grove, PA
Click here to add this to my saved trials